Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin M Wright

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Oncotarget|April 19, 2014
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicineGavin M Wright, Hongdo Do, Jonathan Weiss, et al.
Clinical Lung Cancer|September 13, 2018
Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging SystemZoe Wainer, Gavin M Wright, Karla Gough, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinomaTimothy D Clay, Hongdo Do, Vijaya Sundararajan, et al.
BMC Cancer|March 10, 2011
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancerGenni M Newnham, Matthew Conron, Sueanne McLachlan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 23, 2025
Phase 2 Dose-Ranging Trial of VGT-309 for Molecular Imaging of Cancer during Pulmonary ResectionGavin M Wright, A J Matthew Egan, Jane M Mack, et al.
Pathology|August 17, 2017
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPrudence A Russell, Toni-Maree Rogers, Benjamin Solomon, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
The Medical Journal of Australia|November 19, 2013
Lung cancer in Victoria: are we making progress?Paul L R Mitchell, Vicky J Thursfield, David L Ball, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
Pathology|December 5, 2013
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinomaPrudence A Russell, Yong Yu, Hongdo Do, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Oncotarget|April 19, 2014
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicineGavin M Wright, Hongdo Do, Jonathan Weiss, et al.
Clinical Lung Cancer|September 13, 2018
Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging SystemZoe Wainer, Gavin M Wright, Karla Gough, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinomaTimothy D Clay, Hongdo Do, Vijaya Sundararajan, et al.
BMC Cancer|March 10, 2011
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancerGenni M Newnham, Matthew Conron, Sueanne McLachlan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 23, 2025
Phase 2 Dose-Ranging Trial of VGT-309 for Molecular Imaging of Cancer during Pulmonary ResectionGavin M Wright, A J Matthew Egan, Jane M Mack, et al.
Pathology|August 17, 2017
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPrudence A Russell, Toni-Maree Rogers, Benjamin Solomon, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
The Medical Journal of Australia|November 19, 2013
Lung cancer in Victoria: are we making progress?Paul L R Mitchell, Vicky J Thursfield, David L Ball, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
Pathology|December 5, 2013
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinomaPrudence A Russell, Yong Yu, Hongdo Do, et al.
Pageof 7